Medilys Laborgesellschaft mbH is a subsidiary of the Asklepios Kliniken Hamburg, ensuring laboratory services for thousands of patients 365 days a year. The company plays a crucial role in nearly 70% of all clinical diagnoses with its extensive range of services, including clinical chemistry, hematology, hemostaseology, serology, and molecular genetics. It also provides hygiene services and microbiological examinations to maintain the highest standards of medical care. On an annual basis, Medilys produces around 5 million reports from approximately 19 million analyses and processes about 440,000 submissions for bacteriological diagnostics.
The company operates in the Health Care industry, offering top-notch lab medicine to hospitals, medical practices, and other healthcare facilities nationwide. Despite no specific information on its founding date or headquarters, Medilys Laborgesellschaft has established itself as a key player in the German healthcare sector.
As of now, there is no public record of last investment or involved investors for Medilys Laborgesellschaft mbH. Nevertheless, its significance in the clinical diagnostics and laboratory services market suggests potential interest from investors looking to capitalize on the growing demand for advanced medical testing and analysis.